America November 21, 2023
Takeda Escapes Antitrust Suit Over IBS Drug
In a strategic legal move akin to a grandmaster’s chess play, Takeda Pharmaceuticals sidestepped a potential class action lawsuit. A…
America November 21, 2023
In a strategic legal move akin to a grandmaster’s chess play, Takeda Pharmaceuticals sidestepped a potential class action lawsuit. A…
By Rihem Akkouche